ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Research Assistant at Relation Therapeutics - ApplyBlast

Research Assistant

Relation Therapeutics

7 days ago

3.6 on Glassdoor

London, England, United Kingdom

Onsite

Full Time

Junior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Relation is seeking a Research Assistant with a background in Cell Biology to join an established team running perturbation screens for novel target identification. The role involves designing and executing cellular and biochemical assays, maintaining cell lines, and contributing to data analysis and interpretation. This position offers the opportunity to work at the intersection of science and technology within a rapidly growing TechBio company.

Responsibilities

Design and execute cellular and biochemical assays for drug discovery projects
Maintain primary and immortalised mammalian cell lines with quality control
Conduct genetic perturbation screens and analyze phenotypic data

Skills

Qualifications

Bachelor's degree in a Biological ScienceMaster's degree in a Biological Science

About Relation Therapeutics

relationrx.com

Headquarters

London, England, United Kingdom

Company Size

51-200 employees

Founded

2019

View Profile

Relation Therapeutics is an innovative biotech company dedicated to transforming drug development by leveraging advanced technologies, including single-cell multi-omics and machine learning. Founded in 2020, Relation aims to deepen the understanding of human biology to discover therapies for some of the most challenging diseases. Their interdisciplinary team of experts is focused on developing high-resolution biology-driven medicines, with a clear commitment to addressing urgent medical needs. Based in London, Relation continues to forge strategic partnerships to enhance its therapeutic pipeline.